Medical informatics firm CompuMed reported fiscal second-quarter revenues of $545,000, up 2% compared with the $534,000 reported last year. For the period (end-March 31), the Los Angeles-based firm had a net loss of $101,000, compared with a net loss of $33,000 in the 2005 fiscal second quarter.
CompuMed said the primary reason for the higher loss was an increase in costs related to hiring staff for its sales and R&D departments. CEO Jerry McLaughlin said the company is encouraged with the growth in OsteoGram revenue during the first six months of 2006.
By AuntMinnie.com staff writers
May 15, 2006
Related Reading
CompuMed inks licensing deal with Kodak, April 19, 2006
CompuMed notches remote ECG screening deal, March 14, 2006
CompuMed revenues up in 2005, December 28, 2005
CompuMed, Fuji sign licensing agreement, November 28, 2005
Road to RSNA, CompuMed, November 17, 2005
Copyright © 2006 AuntMinnie.com
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
